These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The new International Health Regulations: considerations for global public health surveillance. Sturtevant JL; Anema A; Brownstein JS Disaster Med Public Health Prep; 2007 Nov; 1(2):117-21. PubMed ID: 18388639 [TBL] [Abstract][Full Text] [Related]
43. Emerging infectious diseases with cutaneous manifestations: Viral and bacterial infections. Nawas ZY; Tong Y; Kollipara R; Peranteau AJ; Woc-Colburn L; Yan AC; Lupi O; Tyring SK J Am Acad Dermatol; 2016 Jul; 75(1):1-16. PubMed ID: 27317512 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of ProMED-mail as an electronic early warning system for emerging animal diseases: 1996 to 2004. Cowen P; Garland T; Hugh-Jones ME; Shimshony A; Handysides S; Kaye D; Madoff LC; Pollack MP; Woodall J J Am Vet Med Assoc; 2006 Oct; 229(7):1090-9. PubMed ID: 17014355 [TBL] [Abstract][Full Text] [Related]
46. Bioinformatics tools for the investigation of emerging and re-emerging infectious diseases. Introduction. Vandamme AM Infect Genet Evol; 2009 Jul; 9(4):671. PubMed ID: 19376271 [No Abstract] [Full Text] [Related]
47. Retroviruses and other latent viruses: the deadliest of pathogens are not necessarily the best candidates for bioterrorism. Salgado CD; Kilby JM J S C Med Assoc; 2009 Jun; 105(3):104-6. PubMed ID: 19639767 [TBL] [Abstract][Full Text] [Related]
49. The priorities for antiviral drug resistance surveillance and research. Pillay D J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i57-8. PubMed ID: 17656384 [TBL] [Abstract][Full Text] [Related]
50. [Viruses and bats: rabies and Lyssavirus]. Tordo N; Marianneau MP Bull Mem Acad R Med Belg; 2009; 164(1-2):7-15; discussion 15-6. PubMed ID: 19718950 [TBL] [Abstract][Full Text] [Related]
51. [Emerging and re-emerging infections diseases: risk and response in Algeria]. Mesbah S Med Trop (Mars); 2009 Feb; 69(1):27-32. PubMed ID: 19499728 [TBL] [Abstract][Full Text] [Related]
52. Therapy of newly emerging mutant viral disorders and role in bioterrorism. Ambrus JL; Ambrus JL; Ambrus CM Med Hypotheses; 2005; 64(6):1248-9. PubMed ID: 15823736 [No Abstract] [Full Text] [Related]
54. Virus diseases in man. Anderson T J R Coll Gen Pract; 1969 Sep; 18(86 Suppl 2):1-4. PubMed ID: 5376271 [No Abstract] [Full Text] [Related]
55. [Diagnosis and treatment of viral diseases]. Bonard EC Rev Med Suisse Romande; 1968 Jun; 88(6):436-47. PubMed ID: 5740816 [No Abstract] [Full Text] [Related]
56. Emergential success: a new concept for a better appraisal of viral emergences and reemergences. Chastel C Acta Virol; 2000 Dec; 44(6):375-6. PubMed ID: 11332282 [No Abstract] [Full Text] [Related]
57. The Public Sphere in Emerging Infectious Disease Communication: Recipient or Active and Vocal Partner? Gesser-Edelsburg A; Shir-Raz Y; Walter N; Mordini E; Dimitriou D; James JJ; Green MS Disaster Med Public Health Prep; 2015 Aug; 9(4):447-58. PubMed ID: 26186579 [TBL] [Abstract][Full Text] [Related]
58. Infectious diseases: annual, recurrent and emerging. A review of prehospital management of influenza, pertussis and cholera. Snyder SR; Vitberg DA; Collopy KT EMS World; 2011 Feb; 40(2):44-9. PubMed ID: 21361230 [No Abstract] [Full Text] [Related]
59. A survey of antiviral drugs for bioweapons. Goff AJ; Paragas J Antivir Chem Chemother; 2005; 16(5):283-94. PubMed ID: 16245644 [TBL] [Abstract][Full Text] [Related]